Martin Sutter, Director at Abiomed, holds 13.05M shares in Bioventus (Ticker: BVS), holds 0.00 shares in Abiomed (Ticker: ABMD), holds 1.30M shares in Echo Therapeutics (Ticker: ECTE).

See the Hottest Stocks Based on Insider Trading >

Martin Sutter
Abiomed (ABMD)
Director

Ranked #7,668 out of 98,564 Corporate Insiders

Profitable Transactions

6 out of 10 Profitable Transactions

Average Return

+22.50%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

BVS

A breakdown of Martin Sutter's holdings

See the Top Stocks by Insiders

Insider Roles

Bioventus
(BVS)

Director

Roles that Martin Sutter holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Abiomed
(ABMD)

Rating:Informative Buy

Date:Jun 02, 2015 - Jun 02, 2016

Return:+70.70%

The most profitable trade made by Martin Sutter

See the Latest Stocks Traded by Insiders

Martin Sutter's Trading History

ABMD

Abiomed

Dec 27, 2022

―

Uninformative Sell

―

$0.00

BVS

Bioventus

Jun 13, 2023

Director

Uninformative Buy

―

$56.24M

ECTE

Echo Therapeutics

―

$38.94K

CTIC

CTI BioPharma

―

LJPC

La Jolla Pharma

Aug 07, 2009

―

Informative Sell

403.28K

$0.00

List of latest transactions for each holding click on a transaction to see Martin Sutter's performance on stock

See All Insider Trading from Today

Martin Sutter insider profile FAQ

What is the percentage of profitable transactions made by Martin Sutter?

The percentage of profitable transactions made by Martin Sutter is 60%.

What is the average return per transaction made by Martin Sutter?

The average return per transaction made by Martin Sutter is 22.50%.

What stocks does Martin Sutter hold?

Martin Sutter holds: ABMD, BVS, ECTE, CTIC, LJPC stocks.

What was Martin Sutter’s latest transaction?

Martin Sutter latest transaction was an Uninformative Buy of ―.

What was Martin Sutter's most profitable transaction?

Martin Sutter’s most profitable transaction was an Informative Buy of ABMD stock on June 2, 2015. The return on the trade was 70.70%.

What is Martin Sutter's role in Abiomed?

Martin Sutter's role in Abiomed is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Martin Sutter Insider Profile

Martin Sutter Abiomed (ABMD)Director